Latest Posts

01 Nov 2018

HHS ANSWERS YOUR QUESTIONS ABOUT THE IPI DRUG PRICING MODEL

    By: Dan Best SEE RELATED ARTICLE: https://www.veintherapynews.com/wp-admin/post.php?post=1557&action=edit   Last week, as part of fulfilling President Trump’s promise to lower drug prices and cut down on foreign governments’ freeriding, HHS put forth a new way of paying for physician-administered drugs within Medicare, the International Price Index (IPI) Model. The model aims to:

0
31 Oct 2018

CMS SEEKS COMMENT ON PROPOSED RULE TO USE IPI PAY MODEL BY DEC 31

The Centers for Medicare & Medicaid Services intends to test whether phasing down the Medicare payment amount for selected Part B drugs to more closely align with international prices will meet President Trump’s blueprint to lower drug costs and reduce out-of-pocket costs for patients. CMS is soliciting public comments by

0
30 Oct 2018

AMAZON JOINS ARCADIA GROUP TO LAUNCH CHOICE

Amazon has teamed up with brand consultancy business Arcadia Group to launch a brand of consumer-use medical devices for diabetes and hypertension management, according  to a MedCity report. Called Choice, the new brand will initially include blood glucose monitors and blood pressure monitors accompanied by supporting mobile apps that offer measurement tracking, data mobility and

0
30 Oct 2018

36 HEALTH SYSTEMS FORM THE HEALTHCARE INNOVATORS PROFESSIONAL SOCIETY

As innovation becomes an increasingly important function at many health systems, an exclusive professional organization has formed to provide a supportive community for the chief innovation officers who lead the charge of innovation at not-for-profit organizations. Healthcare Innovators Professional Society (HIPS), composed of innovation leaders from 36 of the nation’s most

0
25 Oct 2018

FCT EMBRACE MARKS FUJIFILM’S ENTRANCE INTO U.S. CT MARKETPLACE

Fujifilm Medical Systems unveiled its FCT Embrace at the 2018 ASTRO annual meeting in October, marking Fujifilm’s entry into the U.S. CT market. The new system, combined with other market-leading oncology solutions, is designed to provide enhanced and efficient CT simulation with radiotherapy treatment planning capabilities. Approved by the FDA,

0
SHARE

Home